Adcendo expands partnership with Duality Biologics
Adcendo has expanded its partnership with fellow biotech company Duality Biologics, in an effort to "broaden and expand" the collaboration.
Adcendo has expanded its partnership with fellow biotech company Duality Biologics, in an effort to "broaden and expand" the collaboration.
AstraZeneca has announced positive high-level data from its DUO-E phase 3 trial for patients with endometrial cancer.